1. A review on experimental surgical models and anesthetic protocols of heart failure in rats
    Ahmed Farag et al, 2023, Frontiers in Veterinary Science CrossRef
  2. Cellular mechanisms and molecular pathways linking bitter taste receptor signalling to cardiac inflammation, oxidative stress, arrhythmia and contractile dysfunction in heart diseases
    Menizibeya O. Welcome et al, 2023, Inflammopharmacology CrossRef
  3. Danshen-Shanzha formula for the treatment of atherosclerosis: ethnopharmacological relevance, preparation methods, chemical constituents, pharmacokinetic properties, and pharmacological effects
    Qiong Xu et al, 2024, Frontiers in Pharmacology CrossRef
  4. Novel lncRNA-miRNA-mRNA Competing Endogenous RNA Triple Networks Associated Programmed Cell Death in Heart Failure
    Yu Zheng et al, 2021, Frontiers in Cardiovascular Medicine CrossRef
  5. Optimized New Shengmai Powder modulation of cAMP/Rap1A signaling pathway attenuates myocardial fibrosis in heart failure
    Zeyu Zhang et al, 2024, Chinese Medicine CrossRef
  6. The traditional Chinese medicines treat chronic heart failure and their main bioactive constituents and mechanisms
    Jie Chen et al, 2023, Acta Pharmaceutica Sinica B CrossRef
  7. A Pharmacological Review of Tanshinones, Naturally Occurring Monomers from Salvia miltiorrhiza for the Treatment of Cardiovascular Diseases
    Ye Yang et al, 2023, Oxidative Medicine and Cellular Longevity CrossRef
  8. The therapeutic effect of tanshinone IIA in mouse astrocytes after treatment with Angiostrongylus cantonensis fifth-stage larval excretory-secretory products
    Kuang-Yao Chen et al, 2023, Journal of Microbiology, Immunology and Infection CrossRef
  9. Tanshinone IIA Accomplished Protection against Radiation-Induced Cardiomyocyte Injury by Regulating the p38/p53 Pathway
    Gang Wang et al, 2022, Mediators of Inflammation CrossRef
  10. New Insights into Mechanisms Traditional Chinese Medicine for Allergic Rhinitis by Regulating Inflammatory and Oxidative Stress Pathways
    Zhu Qin et al, 2024, Journal of Asthma and Allergy CrossRef
  11. Screening and identification of effective components from modified Taohong Siwu decoction for protecting H9c2 cells from damage
    Ya-chao Wang et al, 2023, In Vitro Cellular & Developmental Biology - Animal CrossRef
  12. Signaling pathways and targeted therapy for myocardial infarction
    Qing Zhang et al, 2022, Signal Transduction and Targeted Therapy CrossRef
  13. Intervention effects of traditional Chinese medicine on stem cell therapy of myocardial infarction
    Yu Wang et al, 2022, Frontiers in Pharmacology CrossRef
  14. Evidence and Characteristics of Traditional Chinese Medicine for Coronary Heart Disease Patients With Anxiety or Depression: A Meta-Analysis and Systematic Review
    Baofu Wang et al, 2022, Frontiers in Pharmacology CrossRef
  15. The role of matrix metalloproteinase 9 in fibrosis diseases and its molecular mechanisms
    Yuling Wang et al, 2024, Biomedicine & Pharmacotherapy CrossRef
  16. Post-myocardial infarction fibrosis: Pathophysiology, examination, and intervention
    Xiaoying Yin et al, 2023, Frontiers in Pharmacology CrossRef
  17. STS ⅡA inhibited angiogenesis of lung adenocarcinoma by activating FOXO3 to inhibit CXCL1/STAT3/VEGF pathway
    Bu Wang et al, 2024, Toxicon CrossRef
  18. Qiliqiangxin: A multifaceted holistic treatment for heart failure or a pharmacological probe for the identification of cardioprotective mechanisms?
    Milton Packer, 2023, European Journal of Heart Failure CrossRef
  19. Tanshinone IIA ameliorates myocardial ischemia/reperfusion injury in rats by regulation of NLRP3 inflammasome activation and Th17 cells differentiation
    Dan Li et al, 2022, Acta Cirúrgica Brasileira CrossRef